Mixing COVID Vaccines Produces ‘Robust’ Immunity: Study
Mixing and matching the Pfizer/BioNTech and AstraZeneca-Oxford coronavirus vaccines spawns a “robust” immune response, a new study found.
The Oxford University-ran study, which attempted to determine whether using different brands of vaccines for the initial shot and the follow-up booster vaccination is beneficial, found that the alternating doses of the two vaccine brands elicit strong immunity.
The immune responses differed according to the order of immunization, with the Oxford-AstraZeneca shot followed by the Pfizer/BioNTech vaccine generated the better immune response out of the two mixed schedules, CNBC reported.
The researchers said the vaccine doses were given four weeks apart with data for a 12-week dose interval due in a short period of time.
